Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A comprehensive review of monoamine oxidase inhibitors as Anti-Alzheimer’s disease agents: A review
Shoaib Manzoor, Nasimul Hoda
European Journal of Medicinal Chemistry (2020) Vol. 206, pp. 112787-112787
Closed Access | Times Cited: 178

Showing 26-50 of 178 citing articles:

The genus Palicourea Aubl. (Rubiaceae): source of bioactive compounds
Júlio César Maceda Santivañez, Célio Fernando Figueiredo Angolini
Natural Product Research (2025), pp. 1-15
Closed Access
Promising thiazolidinedione-thiazole based multi-target and neuroprotective hybrids for Alzheimer’s disease: Design, synthesis, in-vitro, in-vivo and in-silico studies
Fahad Hussain, Ayesha Tahir, Hafiz Muzzammel Rehman, et al.
European Journal of Medicinal Chemistry (2025) Vol. 287, pp. 117327-117327
Closed Access
Toxicological landscape of Fuzi: a comprehensive study on the spatial distribution of toxicants and regional neurotoxicity variability in zebrafish
Xiaoqi Pan, Tao Liang, Han Feng, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Therapeutic Role of Heterocyclic Compounds in Neurodegenerative Diseases: Insights from Alzheimer’s and Parkinson’s Diseases
Nidhi Puranik, Minseok Song
Neurology International (2025) Vol. 17, Iss. 2, pp. 26-26
Open Access
Morpholino Pyridazinone Derivatives as Selective Mao-B Inhibitors
Yaren Nur Zenni, Zeynep Özdemir, Selma Saraç, et al.
(2025)
Closed Access
Development of novel melatonin-isatin hybrids as multifunctional agents for Alzheimer’s disease
Yingying Zhong, Jun-Ze Deng, Qin Wang, et al.
Molecular Diversity (2025)
Closed Access
Ferulago angulata Extract Protects against Beta-amyloid-induced Memory Impairment Through Modulation of Monoaminoxidase Enzymes in the Rat’s Hippocampus
Niloofar Mashhadi-Sharif, Maliheh Soodi, Javad Mirnajafi‐Zadeh, et al.
Neurochemical Research (2025) Vol. 50, Iss. 2
Closed Access
Revealing Lingonberry’s Neuroprotective Potential in Alzheimer’s Disease Through Network Pharmacology and Molecular Docking
J Li, Mian Wang, Yi Wang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2363-2363
Open Access
Alzheimer's disease: An evolving understanding of noradrenergic involvement and the promising future of electroceutical therapies
Cody Slater, Qi Wang
Clinical and Translational Medicine (2021) Vol. 11, Iss. 4
Open Access | Times Cited: 33
Diclofenac derivatives as concomitant inhibitors of cholinesterase, monoamine oxidase, cyclooxygenase-2 and 5-lipoxygenase for the treatment of Alzheimer's disease: synthesis, pharmacology, toxicity and docking studies
Muhammad Aamir Javed, Saba Bibi, Muhammad Saeed Jan, et al.
RSC Advances (2022) Vol. 12, Iss. 35, pp. 22503-22517
Open Access | Times Cited: 26
Diagnostic and therapeutic potential of protease inhibition
Natalia Ćwilichowska, K. Świderska, Agnieszka Dobrzyń, et al.
Molecular Aspects of Medicine (2022) Vol. 88, pp. 101144-101144
Closed Access | Times Cited: 24
An ongoing journey of chalcone analogues as single and multi-target ligands in the field of Alzheimer's disease: A review with structural aspects
Pratibha Sharma, Manjinder Singh
Life Sciences (2023) Vol. 320, pp. 121568-121568
Closed Access | Times Cited: 14
Pathogenesis of Alzheimer’s Disease and Diversity of 1,2,3-Triazole Scaffold in Drug Development: Design Strategies, Structural Insights, and Therapeutic Potential
Atamjit Singh, Karanvir Singh, Jashandeep Kaur, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 18, pp. 3291-3317
Closed Access | Times Cited: 12
In silico approach of 2,5-Diketopiperazines from marine organisms to neurodegenerative diseases
Rodrigo Chico-Merino, Antonio Rosales-López, Joel L. Terán, et al.
GSC Biological and Pharmaceutical Sciences (2024) Vol. 26, Iss. 1, pp. 094-106
Open Access | Times Cited: 4
HDAC6-Activatable Multifunctional Near-Infrared Probe for Glioma Cell Detection and Elimination
Wenyu Wei, Chen Huang, Jie Zhang, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 6, pp. 2406-2414
Closed Access | Times Cited: 4
Research progress in biological activities of isochroman derivatives
Zefeng Zhao, Kaiwen Kang, Jiangxin Yue, et al.
European Journal of Medicinal Chemistry (2020) Vol. 210, pp. 113073-113073
Closed Access | Times Cited: 34
Trimethoxylated Halogenated Chalcones as Dual Inhibitors of MAO-B and BACE-1 for the Treatment of Neurodegenerative Disorders
Vishal Payyalot Vishal, Jong‐Min Oh, Ahmed Khames, et al.
Pharmaceutics (2021) Vol. 13, Iss. 6, pp. 850-850
Open Access | Times Cited: 29
Mitochondria targeting fluorescent probe for MAO-A and the application in the development of drug candidate for neuroinflammation
Jia‐Rong Wu, Chaoyan Han, Xudong Cao, et al.
Analytica Chimica Acta (2022) Vol. 1199, pp. 339573-339573
Closed Access | Times Cited: 21
Phytoestrogen Coumestrol Selectively Inhibits Monoamine Oxidase-A and Amyloid β Self-Aggregation
Su Hui Seong, Boram Kim, Myoung Lae Cho, et al.
Nutrients (2022) Vol. 14, Iss. 18, pp. 3822-3822
Open Access | Times Cited: 19
Design, Synthesis, and Biological Evaluation of Novel MAO-A Inhibitors Targeting Lung Cancer
Sanaa K. Bardaweel, Reem Aljanabi, Dima A. Sabbah, et al.
Molecules (2022) Vol. 27, Iss. 9, pp. 2887-2887
Open Access | Times Cited: 18
A fluorogenic-inhibitor-based probe for profiling and imaging of monoamine oxidase A in live human glioma cells and clinical tissues
Haixiao Fang, Panpan Li, Congzhen Shen, et al.
Science China Chemistry (2023) Vol. 66, Iss. 7, pp. 2053-2061
Closed Access | Times Cited: 10
Monoamine oxidase B inhibitors based on natural privileged scaffolds: A review of systematically structural modification
Yangjing Lv, Zhiyuan Zheng, Renzheng Liu, et al.
International Journal of Biological Macromolecules (2023) Vol. 251, pp. 126158-126158
Closed Access | Times Cited: 10
Synthesis, characterization, molecular docking and molecular dynamics simulations of novel 2,5-disubstituted-1,3,4-thiadiazole derivatives as potential cholinesterase/monoamine oxidase dual inhibitors for Alzheimer’s disease
Amal A. AL-Sharabi, Asaf Evrim Evren, Begüm Nurpelin Sağlık, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 23, pp. 13023-13041
Closed Access | Times Cited: 10
Development of morpholine ring-bearing halogenated α,β-unsaturated ketones as selective monoamine oxidase-B inhibitors
Jiseong Lee, Saranya Kattil Parmbil, Nagendar Kumar Pandit, et al.
Applied Biological Chemistry (2024) Vol. 67, Iss. 1
Open Access | Times Cited: 3
Small molecule probes for the specific imaging of monoamine oxidase A and monoamine oxidase B
Yi Fang, Zhengping Chen, Min Yang
iRadiology (2024) Vol. 2, Iss. 2, pp. 191-215
Open Access | Times Cited: 3

Scroll to top